--- title: How do PMDD treatments affect sleep? | Niyora description: This review examines how PMDD treatments like SSRIs affect sleep and circadian rhythms, but current research is limited. More research is needed to fully unde url: https://niyora.com/research/papers/the-impact-of-pharmacotherapy-for-premenstrual-dysphoric-disorder-on-sleep-2025/ --- - [Niyora](https://niyora.com/) - [Research](https://niyora.com/research/) - [Library](https://niyora.com/research/library/) - How do PMDD treatments affect sleep? Survey study, 2025 # How do PMDD treatments affect sleep? This review examines how PMDD treatments like SSRIs affect sleep and circadian rhythms, but current research is limited. More research is needed to fully understand these effects. Early or limited evidence Review of published research (not a study of specific women) ## What they did Literature review examining how PMDD symptoms relate to sleep and circadian rhythms, and how medications used to treat PMDD affect sleep quality and melatonin levels. ## What they found The review describes how serotonin problems, disrupted progesterone-related brain chemicals, and disturbed circadian rhythms all contribute to PMDD and sleep disruption. It discusses that SSRIs and sedatives can help, but their exact effects on sleep and melatonin are not well understood. ## What it means for you PMDD treatments may help mood symptoms, but we do not fully understand how they affect sleep and the body clock. Better understanding of this relationship could help doctors treat both the mood and sleep aspects of PMDD more effectively. ## About the study Original title The impact of pharmacotherapy for premenstrual dysphoric disorder on sleep Authors Meth EMS, Nôga DA, Dubol M et al. Journal Sleep medicine reviews Year 2025 Study design Survey study What was tested SSRIs, sleep medications Open access Yes Read the paper [doi.org/10.1016/j.smrv.2025.102069](https://doi.org/10.1016/j.smrv.2025.102069) Original abstract Premenstrual dysphoric disorder (PMDD) affects a subset of women of reproductive age, characterized by severe mood disturbances and physical symptoms during the luteal phase of the menstrual cycle. Symptoms include mood swings, irritability, anxiety, fatigue, physical discomfort, and disruptions to sleep and circadian rhythms, such as altered melatonin secretion. Despite the prevalence of these symptoms, the impact of PMDD treatments on sleep and circadian markers, like melatonin, remains insufficiently understood. This review examines how dysregulated serotonin signaling, disrupted allopregnanolone activity (a neurosteroid derived from progesterone), and aberrant circadian rhythms contribute to PMDD. It also explores the effects of pharmacological treatments, including selective serotonin reuptake inhibitors, on sleep and melatonin regulation, and how these factors influence treatment outcomes. Additionally, the use of hypnotics and sedatives to manage sleep disturbances in PMDD is considered, weighing their potential benefits and risks. A deeper understanding of the interaction between PMDD symptoms, sleep, and circadian rhythms is crucial for developing more effective treatments. Further research is needed to explore the relationship between symptom management, sleep patterns, and circadian function in PMDD, and to determine how these factors can be optimized to improve clinical outcomes and quality of life for women affected by the disorder. Reproduced under CC-BY. ## Topics [Premenstrual dysphoric disorder (PMDD)](https://niyora.com/research/topics/condition-pmdd/)[Menstrual cycle and mood](https://niyora.com/research/topics/condition-cycle-mood/)[Low mood and depression](https://niyora.com/research/topics/symptom-depression-mood/)[Sleep and insomnia](https://niyora.com/research/topics/symptom-sleep/)[SSRIs and antidepressants](https://niyora.com/research/topics/treatment-ssri/)[Oral contraceptives and drospirenone](https://niyora.com/research/topics/treatment-hormonal-contraceptives/)[GnRH agonists and ovarian suppression](https://niyora.com/research/topics/treatment-gnrh/)[Neurosteroids (allopregnanolone)](https://niyora.com/research/topics/treatment-neurosteroids/) Research tells you what helps on average. Niyora helps on the day it hits. Calm down, see it another way, and decide what to say, with a PMS and PMDD app built by a doctor. ## Related studies Study, 2026 What treatments work for PMDD? Systematic review, 2024 What are the best treatments for PMDD and PMS? Systematic review, 2022 What are the best treatments for PMDD and PMS? Review, 2015 What do we know about PMS and PMDD and how are they treated? Review, 2008 What medications are FDA-approved for treating PMDD? Randomised trial, 2017 Does Sepranolone reduce symptoms of severe premenstrual syndrome (PMDD)? Ask AI about this page Copy prompt ChatGPT ↗ Claude ↗ Perplexity ↗ Google AI Mode ↗ Grok ↗